NKE

NIKE, Inc.

60
Fundamentals56/ 100
Valuation80/ 100
Upside potential58/ 100
Risk potential18/ 100

NKE offers stronger valuation, but that advantage does not outweigh its weaker overall profile.

RCKY

Rocky Brands, Inc.

73
Fundamentals72/ 100
Valuation67/ 100
Upside potential76/ 100
Risk potential18/ 100

RCKY has the edge over NKE overall, supported by stronger modeled upside and stronger fundamentals.

NKE Fundamentals

MetricStatus
Stable
Healthy
Stable
Strong

NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.

RCKY Fundamentals

MetricStatus
Healthy
Healthy
Healthy
Healthy

RCKY's revenue, profitability, cash flow and balance sheet are all currently healthy.

NKE PE Valuation

CHEAPFAIREXPENSIVE21x43x64x86x
CHEAPFAIREXPENSIVE21x43x64x86x
LevelPEPriceVs current
Current18x$37.76—
Cheap23x$47.70+26%
Forward30x$37.76—
Fair33x$68.16+80%
Expensive47x$97.86+159%

Historical ranges are pointers, not guarantees.

NKE has the edge over RCKY in the historical PE scenario, which offers more potential upside but is not a forecast.

RCKY PE Valuation

CHEAPFAIREXPENSIVE5.7x11x17x23x
CHEAPFAIREXPENSIVE5.7x11x17x23x
LevelPEPriceVs current
Cheap10x$46.61-9.9%
Current11x$51.71—
Fair13x$58.73+14%
Forward13x$51.71—
Expensive17x$75.66+46%

Historical ranges are pointers, not guarantees.

RCKY's PE is in its cheap range at 11x. On analysts' estimates for next year's earnings, today's price would be 13x, in its fair range.

NKE Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Decline
Improving
Moderate
Low

Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.

RCKY Forward outlook

MetricOutlook
Deteriorating
Strong growth
Growth
Improving
Limited
High

RCKY has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.

NKE Risk to reward

ScenarioChangePrice
Upside+25%$47.36
Downside-18%$30.83

Calculated from the latest close: $37.76 on Nov 12.

NKE trails RCKY on modeled risk to reward, with less potential upside and more potential downside.

RCKY Risk to reward

ScenarioChangePrice
Upside+54%$79.89
Downside-18%$42.65

Calculated from the latest close: $51.71 on Nov 12.

RCKY has a better modeled risk to reward balance than NKE, with more potential upside and less potential downside.

NKE Earnings Per Share

Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27-39%
Q3 2026$2.09+7.2%
Q2 2026$2.10-2.8%
Q1 2026$1.51-50%
Q4 2025$1.70-48%
Q3 2025$1.95-44%
Q2 2025$2.16-42%
Q1 2025$3.01-11%
Q4 2024$3.24-5.3%

NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.

RCKY Earnings Per Share

Q4 2023: $1.41Q1 2024: $1.80Q2 2024: $2.00Q3 2024: $1.77Q4 2024: $1.52Q1 2025: $1.84Q2 2025: $2.49Q3 2025: $2.75Q4 2025: $2.96Q1 2026: $2.47Q2 2026: $3.82Q3 2026: $4.55Forward: $4.09
Q4 2023: $1.41Q1 2024: $1.80Q2 2024: $2.00Q3 2024: $1.77Q4 2024: $1.52Q1 2025: $1.84Q2 2025: $2.49Q3 2025: $2.75Q4 2025: $2.96Q1 2026: $2.47Q2 2026: $3.82Q3 2026: $4.55Forward: $4.09
QuarterTTM EPSYoY
Forward$4.09-10%
Q3 2026$4.55+65%
Q2 2026$3.82+53%
Q1 2026$2.47+34%
Q4 2025$2.96+95%
Q3 2025$2.75+55%
Q2 2025$2.49+25%
Q1 2025$1.84+2.2%
Q4 2024$1.52+7.8%

RCKY has the edge over NKE on earnings, with more consistent year-over-year improvement.

NKE Quarterly Revenue

Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
QuarterRevenueYoY
Q3 2026$11.2B-4.3%
Q2 2026$11B-1.1%
Q1 2026$11.3B+0.1%
Q4 2025$12.4B+0.6%
Q3 2025$11.7B+1.1%
Q2 2025$11.1B-12%
Q1 2025$11.3B-9.3%
Q4 2024$12.4B-7.7%

NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.

RCKY Quarterly Revenue

Q4 2023: $126MQ1 2024: $113MQ2 2024: $98MQ3 2024: $115MQ4 2024: $128MQ1 2025: $114MQ2 2025: $106MQ3 2025: $123MQ4 2025: $140MQ1 2026: $124MQ2 2026: $118MQ3 2026: $139M
Q4 2023: $126MQ1 2024: $113MQ2 2024: $98MQ3 2024: $115MQ4 2024: $128MQ1 2025: $114MQ2 2025: $106MQ3 2025: $123MQ4 2025: $140MQ1 2026: $124MQ2 2026: $118MQ3 2026: $139M
QuarterRevenueYoY
Q3 2026$138.8M+13%
Q2 2026$118.4M+12%
Q1 2026$124.4M+9.1%
Q4 2025$139.7M+9.1%
Q3 2025$122.5M+7%
Q2 2025$105.6M+7.5%
Q1 2025$114.1M+1%
Q4 2024$128.1M+1.7%

RCKY has the edge over NKE on sales, with more consistent year-over-year improvement.

NKE Free Cash Flow

Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
QuarterFree cash flowYoY
Q3 2026-$64M-527%
Q2 2026$1.5B+313%
Q1 2026$284M-83%
Q4 2025$386M-58%
Q3 2025$15M-95%
Q2 2025$363M-85%
Q1 2025$1.7B-11%
Q4 2024$920M-65%

NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.

RCKY Free Cash Flow

Q4 2023: $41MQ1 2024: $17MQ2 2024: $5MQ3 2024: $3MQ4 2024: $23MQ1 2025: $529,000Q2 2025: −$2MQ3 2025: −$5MQ4 2025: $17MQ1 2026: $744,000Q2 2026: $4MQ3 2026: $6M
Q4 2023: $41MQ1 2024: $17MQ2 2024: $5MQ3 2024: $3MQ4 2024: $23MQ1 2025: $529,000Q2 2025: −$2MQ3 2025: −$5MQ4 2025: $17MQ1 2026: $744,000Q2 2026: $4MQ3 2026: $6M
QuarterFree cash flowYoY
Q3 2026$6.3M+$11.4M
Q2 2026$4.1M+$6.5M
Q1 2026$744K+41%
Q4 2025$16.7M-27%
Q3 2025-$5.2M-249%
Q2 2025-$2.4M-151%
Q1 2025$529K-97%
Q4 2024$22.9M-45%

RCKY has the edge over NKE on cash flow, with more consistent year-over-year improvement.

NKE Total Shares

Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
PeriodChange %Net change
Quarterly+0.2%+3.2M shares
1 year+0.4%+5.2M shares
3 years-3.8%-59.1M shares
5 years-8.4%-135M shares
Available history-6.9%-110M shares

NKE has the edge over RCKY on shareholder dilution, with a more favorable share count trend.

RCKY Total Shares

Q4 2023: 7MQ1 2024: 7MQ2 2024: 7MQ3 2024: 8MQ4 2024: 7MQ1 2025: 7MQ2 2025: 7MQ3 2025: 8MQ4 2025: 8MQ1 2026: 8MQ2 2026: 8MQ3 2026: 8M
Q4 2023: 7MQ1 2024: 7MQ2 2024: 7MQ3 2024: 8MQ4 2024: 7MQ1 2025: 7MQ2 2025: 7MQ3 2025: 8MQ4 2025: 8MQ1 2026: 8MQ2 2026: 8MQ3 2026: 8M
PeriodChange %Net change
Quarterly+0.3%+21K shares
1 year+1%+76K shares
3 years+3.3%+244K shares
5 years+3.4%+249K shares
Available history+2.4%+180K shares

RCKY has 8M diluted shares, up 1% from a year ago.

NKE Net Leverage

Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
QuarterNet LeverageStatus
Q3 20260.2xVery low
Q2 20260.1xVery low
Q1 20250.1xVery low
Q4 20240.2xVery low
Q3 20240.1xVery low
Q2 2024-0.1xNet Cash
Q1 2024-0.0xVery low
Q4 20230.1xVery low

NKE has the edge over RCKY on leverage, with a lower net debt burden relative to earnings.

RCKY Net Leverage

Q4 2023: 3.6xQ1 2024: 3.1xQ2 2024: 2.9xQ3 2024: 3.1xQ4 2024: 3.0xQ1 2025: 3.0xQ2 2025: 2.9xQ3 2025: 3.0xQ4 2025: 2.6xQ1 2026: 2.9xQ2 2026: 2.2xQ3 2026: 1.9x
Q4 2023: 3.6xQ1 2024: 3.1xQ2 2024: 2.9xQ3 2024: 3.1xQ4 2024: 3.0xQ1 2025: 3.0xQ2 2025: 2.9xQ3 2025: 3.0xQ4 2025: 2.6xQ1 2026: 2.9xQ2 2026: 2.2xQ3 2026: 1.9x
QuarterNet LeverageStatus
Q3 20261.9xHealthy
Q2 20262.2xModerate
Q1 20262.9xModerate
Q4 20252.6xModerate
Q3 20253.0xModerate
Q2 20252.9xModerate
Q1 20253.0xElevated
Q4 20243.0xElevated

RCKY's net debt is about 1.9 years of its operating earnings (EBITDA), down from 3.0 years a year ago.

NKE Weekly Momentum

MetricValueStatus
RSI40.0Neutral
Stochastic57.5Neutral

NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).

RCKY Weekly Momentum

MetricValueStatus
RSI68.5Neutral
Stochastic70.6Neutral

RCKY's weekly RSI is 69 (neutral) and its Stochastic is 71 (neutral).

NKE PE vs Consumer Cyclical Sector

MetricNKESector medianRelative
PE18x18x0.3% above
PE %24745 pts below

NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.

RCKY PE vs Consumer Cyclical Sector

MetricRCKYSector medianRelative
PE11x18x37% below
PE %284719 pts below

RCKY has the edge over NKE on valuation relative to its sector.

NKE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$36.72.8% above
20 week MA$39.23.6% below
50 week MA$48.021% below
100 week MA$58.435% below
200 week MA$79.252% below

NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.

RCKY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$47.78.4% above
20 week MA$45.713% above
50 week MA$40.229% above
100 week MA$32.062% above
200 week MA$29.079% above

RCKY has the edge over NKE on trend strength, trading above more of its moving averages.

NKE Yearly ROI

YearStart priceEnd priceROI
2020$101.6$141.6+39%
2021$141.6$165.7+17%
2022$165.7$116.3-30%
2023$116.3$108.6-6.6%
2024$108.6$76.4-30%
2025$76.4$60.9-20%
2026 YTD$60.9$37.8-38%

NKE has finished four years in a row lower, and it's down 38% so far in 2026.

RCKY Yearly ROI

YearStart priceEnd priceROI
2020$28.7$28.70%
2021$28.7$38.6+35%
2022$38.6$24.0-38%
2023$24.0$30.2+26%
2024$30.2$22.5-25%
2025$22.5$30.0+33%
2026 YTD$30.0$51.7+72%

RCKY has the edge over NKE on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key